Table 2.
The body weight and lens opacity of cataractous rats after four weeks treatment with rHV3 eye drops ().
Group | n | Body weight (g) | Lens opacity |
---|---|---|---|
A | 16 | 360.69 ± 31.63** | 0.19 ± 0.40∗∗## |
B | 13 | 170.85 ± 28.65 | 3.69 ± 0.63 |
C | 13 | 170.15 ± 26.70 | 2.00 ± 0.82∗∗## |
D | 14 | 164.93 ± 14.58 | 1.86 ± 0.53∗∗## |
E | 15 | 166.73 ± 32.30 | 1.73 ± 0.46∗∗## |
F | 12 | 171.25 ± 29.89 | 3.00 ± 0.85 |
**P < 0.01 versus group B (model, treated with eye drops vehicle).
## P < 0.01 versus group F (pirenoxine treated).